Oruka Therapeutics (ORKA) Depreciation & Amortization (CF) (2010 - 2026)
Oruka Therapeutics' quarterly Depreciation & Amortization (CF) came in at $43000.0 in Q1 2026, up 168.75% year-on-year from $16000.0 in Q1 2025, and up 53.57% quarter-over-quarter from $28000.0 in Q4 2025.
Oruka Therapeutics has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $43000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 168.75% year-over-year to $43000.0; the trailing twelve-month figure through Mar 2026 stood at $110000.0 (up 214.29% YoY), and the FY2025 full-year result was $83000.0, up 207.41% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $43000.0, up from $28000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $43000.0 in Q1 2026, with the low at $3000.0 in Q4 2023.
- Average Depreciation & Amortization (CF) over 5 years is $11437.5, with a median of $5000.0 recorded in 2022.
- Year-over-year, Depreciation & Amortization (CF) plunged 40.0% in 2023 and soared 533.33% in 2025.
- Tracing ORKA's Depreciation & Amortization (CF) over 5 years: stood at $5000.0 in 2022, then sank by 40.0% to $3000.0 in 2023, then surged by 433.33% to $16000.0 in 2024, then soared by 75.0% to $28000.0 in 2025, then surged by 53.57% to $43000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $43000.0 (Q1 2026), $28000.0 (Q4 2025), and $20000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | 43,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,000.00 |
| Mar 31, 2026 | 43,000.00 |
| Dec 31, 2025 | 28,000.00 |
| Dec 31, 2025 | 28,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 5,000.00 |
| Dec 31, 2022 | 5,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Sep 30, 2020 | 2,000.00 |
| Sep 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Sep 30, 2019 | 5,000.00 |
| Sep 30, 2019 | 5,000.00 |
| Jun 30, 2019 | 6,000.00 |
| Jun 30, 2019 | 6,000.00 |
| Mar 31, 2019 | 5,000.00 |
| Mar 31, 2019 | 5,000.00 |
| Dec 31, 2018 | 5,000.00 |
| Dec 31, 2018 | 5,000.00 |
| Sep 30, 2018 | 6,000.00 |
| Sep 30, 2018 | 6,000.00 |
| Jun 30, 2018 | 5,000.00 |
| Jun 30, 2018 | 5,000.00 |
| Mar 31, 2018 | 6,000.00 |
| Mar 31, 2018 | 6,000.00 |
| Dec 31, 2017 | 6,000.00 |
| Dec 31, 2017 | 6,000.00 |
| Sep 30, 2017 | 7,000.00 |
| Sep 30, 2017 | 7,000.00 |
| Jun 30, 2017 | 7,000.00 |
| Jun 30, 2017 | 7,000.00 |
| Mar 31, 2017 | 7,000.00 |
| Mar 31, 2017 | 7,000.00 |
| Dec 31, 2016 | 7,000.00 |
| Dec 31, 2016 | 7,000.00 |
| Sep 30, 2016 | 8,000.00 |
| Sep 30, 2016 | 8,000.00 |
| Jun 30, 2016 | 4,000.00 |
| Jun 30, 2016 | 4,000.00 |
| Mar 31, 2016 | 5,000.00 |
| Mar 31, 2016 | 5,000.00 |
| Dec 31, 2015 | 5,000.00 |
| Dec 31, 2015 | 5,000.00 |
| Sep 30, 2015 | 5,000.00 |
| Sep 30, 2015 | 5,000.00 |
| Jun 30, 2015 | 5,000.00 |
| Jun 30, 2015 | 5,000.00 |
| Mar 31, 2015 | 4,000.00 |
| Mar 31, 2015 | 4,000.00 |
| Dec 31, 2014 | 4,000.00 |
| Dec 31, 2014 | 4,000.00 |
| Sep 30, 2014 | 3,000.00 |
| Sep 30, 2014 | 3,000.00 |
| Jun 30, 2014 | 2,000.00 |
| Jun 30, 2014 | 2,000.00 |
| Mar 31, 2014 | 3,000.00 |
| Mar 31, 2014 | 3,000.00 |
| Dec 31, 2013 | 2,000.00 |
| Dec 31, 2013 | 2,000.00 |
| Sep 30, 2013 | 5,000.00 |
| Sep 30, 2013 | 5,000.00 |
| Jun 30, 2013 | 9,000.00 |
| Jun 30, 2013 | 9,000.00 |
| Mar 31, 2013 | 10,000.00 |
| Mar 31, 2013 | 10,000.00 |
| Dec 31, 2012 | 9,000.00 |
| Dec 31, 2012 | 9,000.00 |
| Sep 30, 2012 | 10,000.00 |
| Sep 30, 2012 | 10,000.00 |
| Jun 30, 2012 | 10,000.00 |
| Jun 30, 2012 | 10,000.00 |
| Mar 31, 2012 | 14,000.00 |
| Mar 31, 2012 | 14,000.00 |
| Dec 31, 2011 | 84,000.00 |
| Dec 31, 2011 | 84,000.00 |
| Sep 30, 2011 | 323,000.00 |
| Sep 30, 2011 | 323,000.00 |
| Jun 30, 2011 | 114,000.00 |
| Jun 30, 2011 | 114,000.00 |
| Mar 31, 2011 | 81,000.00 |
| Mar 31, 2011 | 81,000.00 |
| Dec 31, 2010 | 83,000.00 |
| Dec 31, 2010 | 83,000.00 |
| Sep 30, 2010 | 84,000.00 |
| Sep 30, 2010 | 84,000.00 |